pembrolizumab
merck
['keynote-522', 'tnbc', 'key,note,52', 'pembro']
important data at #esmo22 on hrqol with (neo)adjuvant pembrolizumab in keynote-522 presented by : no meaningful differences in hrqol between the two treatment arms. these data support pembro in early #tnbc, yet iraes require further (e.g, on fertility) 
MD, Medical Oncologist????•Research Fellow at @JulesBordet Institute in Brussels???? Great interest in #BreastCancer and #ImmunoOncology